Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign prostatic hypertrophy.

W M O'Brien1

  • 1Georgetown University Hospital, Washington, D.C.

American Family Physician
|July 1, 1991
PubMed
Summary

Benign prostatic hypertrophy (BPH) affects 10-25% of men by age 75, causing urinary symptoms. Transurethral resection of the prostate is effective, but recurrence or cancer is possible.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute scrotal swelling in Henoch-Schonlein syndrome: evaluation with testicular scanning.

Urology·1993
Same author

Percutaneous placement of a suprapubic tube with peel away sheath introducer.

The Journal of urology·1991
Same author

Simplification of double-dye test to diagnose various types of vaginal fistulas.

Urology·1990
Same author

Percutaneous nephrostomy in infants.

Urology·1990
Same author

Priapism: current concepts.

Annals of emergency medicine·1989
Same author

Adjunctive endourological technique for transurethral resection in patients with urethral stricture.

The Journal of urology·1989

Area of Science:

  • Urology
  • Geriatric Medicine
  • Men's Health

Background:

  • Benign prostatic hypertrophy (BPH) is a common condition in aging men.
  • 10-25% of men aged 75+ require intervention for BPH.
  • Symptoms range from bladder outlet obstruction to irritability, impacting quality of life.

Purpose of the Study:

  • To review the indications for and treatment options for benign prostatic hypertrophy.
  • To highlight the efficacy and limitations of current BPH interventions.

Main Methods:

  • Literature review of BPH symptoms, indications for treatment, and therapeutic modalities.
  • Analysis of established and emerging treatment options for BPH.

Main Results:

  • Transurethral resection of the prostate (TURP) is the primary treatment, offering 85% relief.
  • Newer options include alpha-adrenergic blockers, antiandrogens, and balloon dilatation.
  • Potential for prostate cancer or BPH recurrence exists post-TURP.

Conclusions:

  • BPH management requires careful consideration of symptoms and patient factors.
  • TURP remains a highly effective, though not risk-free, treatment for BPH.
  • Ongoing research into novel therapies aims to improve BPH treatment outcomes.

Related Experiment Videos